Page last updated: 2024-08-17

acridine yellow and Glioblastoma

acridine yellow has been researched along with Glioblastoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chan, CB; Fu, H; He, K; Liu, X; Mao, H; Mischel, PS; Olson, JJ; Qi, Q; Ramalingam, SS; Sun, SY; Tao, H; Wang, L; Xiao, G; Ye, K; Yoo, MH; Zhang, Z	1

Other Studies

1 other study(ies) available for acridine yellow and Glioblastoma

Article	Year
Acridine yellow G blocks glioblastoma growth via dual inhibition of epidermal growth factor receptor and protein kinase C kinases. The Journal of biological chemistry, 2012, Feb-24, Volume: 287, Issue:9 Topics: Aminoacridines; Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Drug Screening Assays, Antitumor; ErbB Receptors; Female; G1 Phase; Glioblastoma; Humans; Mice; Mice, Nude; Protein Kinase C; Protein Kinase Inhibitors; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays	2012

Article

Year

Acridine yellow G blocks glioblastoma growth via dual inhibition of epidermal growth factor receptor and protein kinase C kinases.

The Journal of biological chemistry, 2012, Feb-24, Volume: 287, Issue:9

Topics: Aminoacridines; Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Drug Screening Assays, Antitumor; ErbB Receptors; Female; G1 Phase; Glioblastoma; Humans; Mice; Mice, Nude; Protein Kinase C; Protein Kinase Inhibitors; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2012